Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome

Cornea

Volumn 25, Issue 3, 2006, Pages 268-272

  Yoon, Kyung Chul ^a,c   Im, Seong Kyu ^a   Park, Yeoung Geol ^a   Jung, Young Do ^a   Yang, Seong Yeul ^a   Choi, Jin ^b  

^a Chonnam National University Medical School   (South Korea)

^b Eun Hospital   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Dry eye syndrome; Epidermal growth factor; Transforming growth factor ; Umbilical cord serum eyedrops; Vitamin A

Indexed keywords

ARTIFICIAL TEAR; CHONDROITIN SULFATE; EPIDERMAL GROWTH FACTOR; EYE DROPS; HYALEIN; HYALURONIC ACID; RETINOL; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BLOOD LEVEL; CELL DENSITY; CLINICAL ARTICLE; CONJUNCTIVA; CORNEA SENSIBILITY; CYTOLOGY; DISEASE SEVERITY; DRY EYE; ENZYME LINKED IMMUNOSORBENT ASSAY; GOBLET CELL; HUMAN; PRIORITY JOURNAL; SCHIRMER TEST; SCORING SYSTEM; SERUM; SYMPTOMATOLOGY; SYNDROME DELINEATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADULT; CORNEA; DRY EYE SYNDROMES; EPIDERMAL GROWTH FACTOR; FEMALE; FETAL BLOOD; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PREGNANCY; PROSPECTIVE STUDIES; TEARS; TRANSFORMING GROWTH FACTOR BETA; VITAMIN A;

EID: 33645957336     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000183484.85636.b6     Document Type: Article

References (27)

1. Ubels J, Loley K., Rismondo V. Retinol secretion by the lacrimal gland. Invest Ophthalmol Vis Sci. 1986;27:1261-1269.
2. Ohashi Y, Motokura M, Kinoshita Y, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989;30:1879-1887.
3. Van Setten G, Tervo T, Tervo K, et al. Epidermal growth factor (EGF) in ocular fluid: presence, origin and therapeutic consideration. Acta Ophthalmol. 1992;202:54-59.
4. Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eye and epithelial defect: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.
5. Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent epithelial defect by autologous serum application. Ophthalmology. 1999;106: 1984-1989.
6. Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.
7. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol. 1999;83:390-395.
8. Goto E, Shimmura S, Shimazaki J, et al. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20:807-810.
9. del Castillo JM, de la Casa JM, Sardina RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21:781-783.
10. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111: 1115-1120.
11. Borderie VM, Mourra N, Laroche L. Influence of fetal calf serum, fibroblast, growth factors, and hepatocyte growth factor on three-dimensional cultures of human keratocytes in collagen gell matrix. Graefes Arch Clin Exp Ophthalmol. 1999;237:861-869.
12. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology. 2001;108:586-592.
13. Inoue K, Kato S, Ohara C, et al. Ocular and systemic factors relevant to diabetic keratoepitheliopathy. Cornea. 2001;20:798-801.
14. Anshu Munshi MM, Sathe V, Ganar A. Conjunctival impression cytology in contact lens wearers. Cytopathology. 2001;12:314-320.
15. Nelson JD. Impression cytology. Cornea. 1988;7:71-81.
16. Gupta A, Monroy DC, Zhonghua J, et al. Transforming growth factor beta-a and beta-2 in human tear film. Curr Eye Res. 1996;15:606-614.
17. Luo W, al-Abdulaly AB, Yoon K, et al. Rapid determination of blood serum retinal by reverse phase open column chromatography. Int J Vitam Nutr Res. 1993;63:82-86.
18. Noble BA, Loh RSK, MacLennan S, et al. Comparison of autologous serum eyedrops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88:647-652.
19. Rodeck U, Jost M, Kari C, et al. EGF-R dependent regulation of keratinocyte survival. J Cell Sci. 1997;110:113-132.
20. Yashino Y, Garg R, Monroy D, et al. Production and secretion of transforming growth factor beta (TGF-β) by the human lacrimal gland. Curr Eye Res. 1996;15:615-624.
21. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000;40:113-122.
22. Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Steven-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.
23. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eyedrops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583.
24. Tananuvat N, Daniell M, Sullivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20:802-806.
25. Lagnado R, King AJ, Donald F, et al. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol. 2004;88:464-465.
26. Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87:1312-1316.
27. Mardarelli F. Diagnosis of human immunodeficiency virus infection. In: Mandell GL, Bennett JE, Dolin R, eds. Principle and Practice of Infectious Diseases. Philadelphia: Elsevier; 2005:1506-1527.